Back to
Deutsche Bank AG
VKTX
Showing 8 of 31 quarters
Position history for
Deutsche Bank AG's holdings in Viking Therapeutics, Inc.
Yes. Deutsche Bank holds 23,695 shares of VKTX (Viking Therapeutics), worth $924,342, as of its Q2 2026 13F filing. It increased the position by 14,994 shares (+172.3%) from Q1 2026. Deutsche Bank has held VKTX in every 13F on record since Q4 2018, 31 quarterly filings.
Current Value
$924,342
Current Shares
23,695
Total Value Change
-$450,182
Total Shares Change
+1,984
Quarter-by-Quarter History